Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for diabetic nephropathy
MOH_2017-07-20_000550Phase 2Recruiting
- Sponsor
- ד"ר שי קיוויתי
- Start
- Feb 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic glomerulosclerosis comparing Standard treatment + placebo with Standard treatment + colchicine (2 arms). Started Feb 2017; status: recruiting.
02
Drugs
colchicine
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on MOH_2017-07-20_000550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-07-20_000550.